Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)

 
   Single User - $2,995
   Site License (one location, 10 users) - $4,495
   Corporate License - $5,990


Loading...
Published Jan 8, 2018 | 134 Pages | Pub ID: KLI15566365

Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)

Immunoassays have played a role in cancer management since the 1960s with the discovery of tumor markers alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA). These two tests are still an essential part of the cancer diagnostics toolbox.

Tumor Markers Immunoassay Market provides analysis of the current global market, including the following data points:
  • Tumor Markers Immunoassay Market by Marker, 2015-2025 (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others, Total)
  • Tumor Markers Immunoassay Market by Region, 2015-2025 (US, EU, ROW, Total)
  • Selected Tumor Marker Immunoassays
  • Attributes of Selected Tumor Marker Immunoassays (Cancer type, Tissue analyzed, How used)
  • Selected Companies Marketing Immunoassays for Tumor Markers
Biomarkers are biological or biochemical molecules, or genetic changes, or other characteristics that can be measured, and that indicate or predict a condition, risk, or likely response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. Much of the activity in the development and use of new biomarkers is in the field of oncology, where both single biomarkers and also biomarker panels are being developed and used for a wide range of applications – assessing risk of developing cancer, screening apparently healthy individuals for cancer, diagnosis of cancer, predicting prognosis, monitoring patients including monitoring for recurrence of disease, and determining the best therapy for treatment of a patient.

For many years, diagnostic assays for cancer have had important roles in diagnosis, determining prognosis, and monitoring of cancer. Early tests for diagnosing, determining prognosis, and monitoring patients with cancer include immunoassays for tumor markers originally developed by Centocor. Fujirebio acquired Centocor Diagnostics in 1998, and Centocor Diagnostics is now called Fujirebio Diagnostics.

Researchers are continuing to try to identify and validate new tumor biomarkers, but this has proven to be a slow process. Still, biomarker assays are being developed and added to the menus of large analyzers.

Assays for these tumor markers are still widely marketed by a large number of companies. Many of these companies are profiled in Tumor Markers Immunoassay Market, including:
  • Abbott Laboratories
  • AccuBioTech Co., Ltd
  • ACON Laboratories, Inc
  • Alere, Inc
  • Alfa Scientific Designs, Inc
  • Artron Laboratories, Inc
  • Atlas Link Biotech Co., Ltd
  • Audit Diagnostics
  • Autobio Diagnostics, Co., Ltd
  • Beckman Coulter, Inc
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd
  • Binding Site Group Ltd
  • Biocare Diagnostics Ltd
  • Biocheck, Inc
  • Biomerica
  • bioMerieux SA
  • Bioscience (Tianjin) Diagnostic Technology Co., Ltd
  • Boson Biotech Co., Ltd
  • Clarity Diagnostics, LLC
  • CTK Biotech, Inc
  • DIALAB GmbH
  • Diametra
  • DiaSorin S.p.A
  • DIAsource ImmunoAssays SA
  • DRG International, Inc
  • Fujirebio US, Inc
  • GlysBy snc
  • Gold Standard Diagnostics
  • LifeSign, LLC
  • Monobind, Inc
  • Novatec Immunodiagnostica GmbH
  • Operon
  • OraSure Technologies, Inc
  • Ortho Clinical Diagnostics
  • Polymedco, Inc
  • Qualigen, Inc
  • Randox Laboratories, Ltd
  • Roche Diagnostic Corporation
  • Siemens Healthineers
  • Syntron Bioresearch, Inc
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc
  • Tosoh Bioscience, Inc
  • Trinity Biotech plc
  • Wako Diagnostics
  • WAMA Diagnostica
  • Executive Summary
    • Overview
      • Table Selected Widely Used Tumor Markers
    • Conclusions
      • The Current Global Market
      • The Tumor Markers Market Is at the Same Time Impressive and Distressing
      • Researchers Are Continuing to Try to Identify and Validate New Tumor Biomarkers
  • Tumor Markers Immunoassay Market: Analysis
    • Tumor Markers
      • Table Selected Tumor Marker Immunoassays
      • Table Attributes of Selected Tumor Marker Immunoassays (Cancer type, Tissue analyzed, How used)
      • AFP (alfa-fetoprotein)
      • Beta HCG
      • CA 125
      • CA 15-3
      • CA 19-9
      • CEA (carcinoembryonic antigen)
      • CYFRA 21-1
      • HE4 (human epididymis protein 4)
      • ProGRP
      • PSA (complexed, free, total))
      • SCC (squamous cell carcinoma antigen)
      • Serum HER-2/neu
      • Thyroglobulin
      • CA 72-4
    • Companies in the Market
      • Table Selected Companies Marketing Immunoassays for Tumor Markers
    • Market Analysis
      • Table Tumor Markers Immunoassay Market by Marker, 2015-2025 ($ millions)
      • Table Tumor Markers Immunoassay Market by Region, 2015-2025 ($ millions) (US, EU, ROW, Total)
  • Company Profiles
    • Abbott Laboratories
      • Table Abbott Corporate Summary
      • Company Overview
      • Product
      • Company Financials
        • Table Abbott Laboratories Revenue (2013-2016) ($ millions)
    • AccuBioTech Co, Ltd.
      • Table AccuBioTech Summary
      • Company Overview
      • Products
    • ACON Laboratories, Inc
      • Table ACON Laboratories Corporate Summary
      • Company Overview
      • Products
    • Alere Inc
      • Table Alere Corporate Summary
      • Company Overview
      • Product
      • Company Financials
        • Table Alere Revenue (2013-2016) ($ millions)
    • Alfa Scientific Designs, Inc
      • Table Alfa Scientific Designs Summary
      • Company Overview
      • Products
    • Artron Laboratories Inc.
      • Table Artron Laboratories Corporate Summary
      • Company Overview
      • Products
    • Atlas Link Biotech Co., Ltd
      • Table Atlas Link Biotech Summary
      • Company Overview
      • Products
    • Audit Diagnostics
      • Table Audit Diagnostics Corporate Summary
      • Company Overview
      • Products
    • Autobio Diagnostics Co., Ltd
      • Table Autobio Diagnostics Summary
      • Company Overview
      • Products
    • Beckman Coulter, Inc
      • Table Beckman Coulter Corporate Summary
      • Company Overview
      • Products
      • Company Financials
        • Table Beckman Coulter (2013-2016) ($ millions)
    • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
      • Table Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
      • Company Overview
      • Products
    • Binding Site Group Ltd.
      • Table Binding Site Group Corporate Summary
      • Company Overview
      • Products
    • Biocare Diagnostics Ltd.
      • Table Biocare Diagnostics Corporate Summary
      • Company Overview
      • Productsi
    • BioCheck, Inc.
      • Table Biocheck Corporate Summary
      • Company Overview
      • Products
    • Biomerica
      • Table Biomerica Summary
      • Company Overview
      • Products
      • Company Financials
        • Table Biomerica (2013-2016) ($ millions)
    • bioMerieux SA
      • Table bioMerieux SA Corporate Summary
      • Company Overview
      • Products
      • Company Financials
        • Table bioMerieux Revenues (2013-2016) ($ millions)
    • Bioscience (Tianjin) Diagnostic Technology Co., Ltd.
      • Table Bioscience (Tianjin) Diagnostic Technology Corporate Summary
      • Company Overview
      • Products
    • Boson Biotech Co. Ltd
      • Table Boson Biotech Summary
      • Company Overview
      • Products
    • Clarity Diagnostics, LLC
      • Table Clarity Diagnostics Corporate Summary
      • Company Overview
      • Products
    • CTK Biotech, Inc.
      • Table CTK Biotech Corporate Summary
      • Company Overview
      • Products
    • DIALAB GmbH
      • Table DIALAB Summary
      • Company Overview
      • Products
    • Diametra
      • Table Diametra Corporate Summary
      • Company Overview
      • Products
    • DiaSorin S.p.A.
      • Table DiaSorin Corporate Summary
      • Company Overview
      • Products
      • Company Financials
        • Table DiaSorin (2013-2016) ($ millions)
    • DIAsource ImmunoAssays SA
      • Table DIAsource ImmunoAssays Corporate Summary
      • Company Overview
      • Products
    • DRG International, Inc.
      • Table DRG International Corporate Summary
      • Company Overview
      • Products
    • Fujirebio US, Inc.
      • Table Fujirebio Corporate Summary
      • Company Overview
      • Products
    • GlysBy snc
      • Table GlysBy Corporate Summary
      • Company Overview
      • Products
    • Gold Standard Diagnostics
      • Table Gold Standard Diagnostics Corporate Summary
      • Company Overview
      • Products
    • LifeSign, LLC
      • Table LifeSign Summary
      • Company Overview
    • Monobind, Inc
      • Table Monobind Corporate Summary
      • Company Overview
      • Products
    • Novatec Immunodiagnostica GmbH
      • Table Novatec Immunodiagnostica Corporate Summary
      • Company Overview
      • Products
    • Operon
      • Table Operon Corporate Summary
      • Company Overview
      • Products
    • OraSure Technologies, Inc.
      • Table OraSure Technologies Corporate Summary
      • Company Overview
      • Products
      • Company Financials
        • Table OraSure Revenue (2013-2016) ($ millions)
    • Ortho Clinical Diagnostics
      • Table Ortho Clinical Diagnostics Corporate Summary
      • Company Overview
      • Products
      • Company Financials
        • Table Ortho Clinical Diagnostics Revenue (2013-2016) ($ millions)
    • Polymedco, Inc
      • Table Polymedco Corporate Summary
      • Company Overview
      • Products
    • Qualigen, Inc.
      • Table Qualigen Corporate Summary
      • Company Overview
      • Products
    • Randox Laboratories Ltd.
      • Table Randox Laboratories Corporate Summary
      • Company Overview
      • Products
    • Roche Diagnostic Corporation
      • Table Roche Corporate Summary
      • Company Overview
      • Products
      • Company Financials
        • Table Roche Revenue (2013-2016) ($ millions)
    • Siemens Healthineers
      • Table Siemens Healthineers Corporate Summary
      • Company Overview
      • Products
      • Company Financials
        • Table Siemens Healthineers Revenue (2013-2016) ($ millions)
    • Syntron Bioresearch, Inc.
      • Table Syntron Bioresearch Corporate Summary
      • Company Overview
      • Products
    • Teco Diagnostics
      • Table Teco Diagnostics Corporate Summary
      • Company Overview
      • Products
    • Thermo Fisher Scientific, Inc
      • Table Thermo Fisher Scientific Corporate Summary
      • Company Overview
      • Products
      • Company Financials
        • Table Thermo Fisher Scientific (2013-2016) ($ millions)
    • Tosoh Bioscience, Inc.
      • Table Tosoh Bioscience Corporate Summary
      • Company Overview
      • Products
      • Company Financials
        • Table Tosoh Corporation (2013-2016) ($ millions)
    • Trinity Biotech plc
      • Table Trinity Biotech Corporate Summary
      • Company Overview
      • Products
      • Company Financials
        • Table Trinity Biotech Revenue (2013-2016) ($ millions)
    • Wako Diagnostics
      • Wako Life Sciences
        • Table Wako Diagnostics Corporate Summary
      • Company Overview
      • Products
    • WAMA Diagnostica
      • Table WAMA Diagnostica Corporate Summary
      • Company Overview
      • Products

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.